Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06101719 · ClinicalTrials.gov registry record
Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction
A clinical trial, sponsored by Children's Hospital Colorado.
- Completed
- Registry status
- 136
- Enrollment target
NCT06101719: Completed study, sponsored by Children's Hospital Colorado.
NCT06101719 is a clinical trial that has completed, run by Children's Hospital Colorado. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06101719 has completed, sponsored by Children's Hospital Colorado.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
The goal of this prospective observational study is to evaluate the diagnostic and therapeutic utility of an enteral contrast challenge for pediatric patients with adhesive small bowel obstruction (ASBO). The aims are to 1. Determine if an enteral contrast challenge is safe in the evaluation of children with ASBO 2. Determine if an enteral contrast challenge decreases the need for operation among children with ASBO Children with ASBO who are cared for at one of 9 participating sites who undergo a trial of non operative management will be observed. Comparisons will be made between those who receive and enteral contrast challenge and those who do not. Outcomes to be evaluated include adverse events related to the contrast, rate of operative intervention, and hospital length of stay.
Primary Outcome
operative lysis of adhesions performed due to failure of non operative management
Interventions
- DIAGNOSTIC_TEST Enteral contrast challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2023-12-31 |
What the finished NCT06101719 record still lists
NCT06101719 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Enteral contrast challenge is the first listed.
NCT06101719 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06101719 about?
NCT06101719 is a clinical study titled "Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction". The goal of this prospective observational study is to evaluate the diagnostic and therapeutic utility of an enteral contrast challenge for pediatric patients with adhesive small bowel obstruction (ASBO). The aims are to 1. Determine if an enteral contrast challenge is safe in the evaluation of chi...
What is the current status of trial NCT06101719?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2020-10-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT06101719?
The interventions under investigation include: Enteral contrast challenge (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06101719?
This trial is sponsored by Children's Hospital Colorado, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI